Preventive therapy for tuberculosis in HIV-infected persons: analysis of policy options based on tuberculin status and CD4+ cell count. Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)

Arch Intern Med. 1998 Oct 26;158(19):2112-21. doi: 10.1001/archinte.158.19.2112.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / economics*
  • AIDS-Related Opportunistic Infections / microbiology
  • AIDS-Related Opportunistic Infections / prevention & control*
  • Antitubercular Agents / economics*
  • Antitubercular Agents / therapeutic use
  • Cost-Benefit Analysis
  • Humans
  • Isoniazid / economics*
  • Isoniazid / therapeutic use
  • Italy
  • Life Expectancy
  • Patient Compliance
  • Prospective Studies
  • Quality-Adjusted Life Years
  • Survival Analysis
  • Tuberculosis / economics*
  • Tuberculosis / etiology
  • Tuberculosis / prevention & control*

Substances

  • Antitubercular Agents
  • Isoniazid